Cargando…

A pilot study on the impact of known drug-drug interactions in cancer patients

BACKGROUND: When a patient concomitantly uses two or more drugs, a drug-drug interaction (DDI) can possibly occur, potentially leading to an increased or decreased clinical effect of a given treatment. Cancer patients are at high risk of such interactions because they commonly receive multiple medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ussai, Silvia, Petelin, Riccardo, Giordano, Antonio, Malinconico, Mario, Cirillo, Donatella, Pentimalli, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547416/ https://www.ncbi.nlm.nih.gov/pubmed/26303220 http://dx.doi.org/10.1186/s13046-015-0201-2

Ejemplares similares

Impact of potential inappropriate NSAIDs use in chronic pain
por: Ussai, S, et al.
Publicado: (2015)

RBL2/p130: a direct AKT substrate and mediator of AKT inhibition-induced apoptosis
por: Ventura, Elisa, et al.
Publicado: (2018)

City-wide electronic health records reveal gender and age biases in administration of known drug–drug interactions
por: Brattig Correia, Rion, et al.
Publicado: (2019)

Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
por: Di Fiore, Riccardo, et al.
Publicado: (2022)

Repeated prescription of known identified drugs with a history of drug allergy
por: Wiwanitkit, Viroj
Publicado: (2011)

Predicting new molecular targets for known drugs
por: Keiser, Michael J., et al.
Publicado: (2009)

RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
por: Indovina, Paola, et al.
Publicado: (2015)

The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?
por: Benot-Dominguez, Reyes, et al.
Publicado: (2022)

“Upcycling” known molecules and targets for drug-resistant TB
por: Roubert, Christine, et al.
Publicado: (2022)

Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
por: Indovina, Paola, et al.
Publicado: (2020)

Drugs and foods from little-known plants : notes in Harvard University herbaria /
por: Von Reis, Siri, 1931-
Publicado: (1973)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Inferring drug-disease associations based on known protein complexes
por: Yu, Liang, et al.
Publicado: (2015)

Known drugs and small molecules in the battle for COVID-19 treatment
por: Panoutsopoulos, Alexios A.
Publicado: (2020)

Antipsychotic Drugs in Prevention of Postoperative Delirium—What Is Known in 2020?
por: Pluta, Michał P., et al.
Publicado: (2020)

Effect of antiepileptic drug comedication on lamotrigine concentrations
por: Lovrić, Mila, et al.
Publicado: (2018)

Restless Legs Syndrome: Known Knowns and Known Unknowns
por: Antelmi, Elena, et al.
Publicado: (2022)

RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways
por: Ventura, Elisa, et al.
Publicado: (2021)

Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships
por: Qu, Xiaoyan A, et al.
Publicado: (2009)

Is There Already a Need of Reckoning on Cancer Immunotherapy?
por: Correale, Pierpaolo, et al.
Publicado: (2021)

Ciprofloxacin and Graphene Oxide Combination—New Face of a Known Drug
por: Matulewicz, Karolina, et al.
Publicado: (2020)

HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation
por: Alfano, Luigi, et al.
Publicado: (2016)

The future of the catalog : the Library's choices /
por: Malinconico, S. Michael
Publicado: (1979)

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
por: Treyer, Andrea, et al.
Publicado: (2019)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

The Italian health system and the COVID-19 challenge
por: Armocida, Benedetta, et al.
Publicado: (2020)

COVID-19: Universal health coverage now more than ever
por: Armocida, Benedetta, et al.
Publicado: (2020)

Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery
por: Astarita, Carlo, et al.
Publicado: (2021)

Clinical relevancy and risks of potential drug–drug interactions in intensive therapy
por: Rodrigues, Aline Teotonio, et al.
Publicado: (2015)

Drug ReposER: a web server for predicting similar amino acid arrangements to known drug binding interfaces for potential drug repositioning
por: Ab Ghani, Nur Syatila, et al.
Publicado: (2019)

Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug
por: Ali, Mennatallah A., et al.
Publicado: (2015)

On ATG4B as Drug Target for Treatment of Solid Tumours—The Knowns and the Unknowns
por: Agrotis, Alexander, et al.
Publicado: (2019)

Target identification among known drugs by deep learning from heterogeneous networks
por: Zeng, Xiangxiang, et al.
Publicado: (2020)

Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023)

Cancer, immunity and inflammation. Report from the CDD Cambridge Conferences 2018 and 2019
por: Liccardi, Gianmaria, et al.
Publicado: (2019)

Interaction of ALK Inhibitors with Polyspecific Organic Cation Transporters and the Impact of Substrate-Dependent Inhibition on the Prediction of Drug–Drug Interactions
por: Tsang, Yik Pui, et al.
Publicado: (2023)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Stroke and Etiopathogenesis: What Is Known?
por: Ciarambino, Tiziana, et al.
Publicado: (2022)

Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2009)

An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds
por: Schake, Philipp, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5qm2d5225njdt8s2h4v82n482o